AU762006B2 - Peptidic product, process and composition - Google Patents

Peptidic product, process and composition Download PDF

Info

Publication number
AU762006B2
AU762006B2 AU22838/00A AU2283800A AU762006B2 AU 762006 B2 AU762006 B2 AU 762006B2 AU 22838/00 A AU22838/00 A AU 22838/00A AU 2283800 A AU2283800 A AU 2283800A AU 762006 B2 AU762006 B2 AU 762006B2
Authority
AU
Australia
Prior art keywords
aceeed
pantp
peptidic
represented
peptidic product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU22838/00A
Other languages
English (en)
Other versions
AU2283800A (en
Inventor
Giulio Gabbiani
Alain Scarso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB SA
Original Assignee
UCB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB SA filed Critical UCB SA
Publication of AU2283800A publication Critical patent/AU2283800A/en
Assigned to UCB reassignment UCB Amend patent request/document other than specification (104) Assignors: UCB S.A.
Application granted granted Critical
Publication of AU762006B2 publication Critical patent/AU762006B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU22838/00A 1998-12-24 1999-12-15 Peptidic product, process and composition Ceased AU762006B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98204396 1998-12-24
EP98204396 1998-12-24
PCT/EP1999/009964 WO2000038733A1 (en) 1998-12-24 1999-12-15 Peptidic product, process and composition

Publications (2)

Publication Number Publication Date
AU2283800A AU2283800A (en) 2000-07-31
AU762006B2 true AU762006B2 (en) 2003-06-19

Family

ID=8234532

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22838/00A Ceased AU762006B2 (en) 1998-12-24 1999-12-15 Peptidic product, process and composition

Country Status (5)

Country Link
US (1) US6335320B1 (cg-RX-API-DMAC10.html)
EP (1) EP1140202A1 (cg-RX-API-DMAC10.html)
JP (1) JP2004513059A (cg-RX-API-DMAC10.html)
AU (1) AU762006B2 (cg-RX-API-DMAC10.html)
WO (1) WO2000038733A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0306165D0 (en) * 2003-03-18 2003-04-23 Delta G Ltd Medical treatment
US20060198800A1 (en) * 2003-08-14 2006-09-07 Natalie Dilallo Skin care compositions including hexapeptide complexes and methods of their manufacture
WO2005016364A1 (en) * 2003-08-14 2005-02-24 Guthy-Renker Corporation Skin care composition including hexapeptide complexes and methods of their manufacture
RU2255757C1 (ru) * 2004-06-22 2005-07-10 Санкт-Петербургская Общественная Организация "Санкт-Петербургский Институт Биорегуляции И Геронтологии Сзо Рамн" Пептидное соединение, восстанавливающее функцию органов дыхания

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004686A1 (en) * 1992-08-21 1994-03-03 Biogen, Inc. Tat-derived transport polypeptides
WO1999011809A1 (en) * 1997-09-02 1999-03-11 Imperial College Innovations Limited Conjugates that contain the homeodomain of antennapedia
WO2000001417A1 (en) * 1998-07-03 2000-01-13 Cyclacel Limited Delivery system

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL296382A1 (en) * 1991-02-02 1993-11-02 Nika Health Products Ltd Li Li Artificial membrane beads containing functionally active peptides responsible for fusion as a drug administering system
US5254342A (en) * 1991-09-30 1993-10-19 University Of Southern California Compositions and methods for enhanced transepithelial and transendothelial transport or active agents
US5534496A (en) * 1992-07-07 1996-07-09 University Of Southern California Methods and compositions to enhance epithelial drug transport
US5837533A (en) * 1994-09-28 1998-11-17 American Home Products Corporation Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
US5846743A (en) * 1995-02-22 1998-12-08 Brigham And Women's Hospital, Inc. Polyphoshoinositide binding peptides for intracellular drug delivery
FR2739621B1 (fr) * 1995-10-05 1997-12-05 Centre Nat Rech Scient Peptides utilisables comme vecteurs pour l'adressage intracellulaire de molecules actives
DE69736351T4 (de) * 1996-05-08 2009-07-23 Cyclacel Ltd. Methoden und mittel zur hemmung der cdk4-aktivität
US6551994B1 (en) * 1997-04-10 2003-04-22 Mcgill University Compounds and methods for inhibiting the interaction between α-catenin and β-catenin
EP1005357A1 (en) * 1997-04-14 2000-06-07 The Regents Of The University Of California Peptide antiestrogen compositions and methods for treating breast cancer
JP2002535247A (ja) * 1998-11-26 2002-10-22 ペンタファルム アクチェンゲゼルシャフト 輸送系複合体

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004686A1 (en) * 1992-08-21 1994-03-03 Biogen, Inc. Tat-derived transport polypeptides
WO1999011809A1 (en) * 1997-09-02 1999-03-11 Imperial College Innovations Limited Conjugates that contain the homeodomain of antennapedia
WO2000001417A1 (en) * 1998-07-03 2000-01-13 Cyclacel Limited Delivery system

Also Published As

Publication number Publication date
US6335320B1 (en) 2002-01-01
WO2000038733A1 (en) 2000-07-06
AU2283800A (en) 2000-07-31
EP1140202A1 (en) 2001-10-10
JP2004513059A (ja) 2004-04-30

Similar Documents

Publication Publication Date Title
US5846743A (en) Polyphoshoinositide binding peptides for intracellular drug delivery
US5132408A (en) Fibroblast growth factor antagonists
AU764277B2 (en) Peptide antiangiogenic drugs
US6638912B2 (en) Peptide compositions mimicking TGF-β activity
JP2001500365A (ja) Ｐ５３とｍｄｍ２の間の相互作用の阻害剤
AU2694400A (en) Novel cyclic tetrapeptide derivatives and use thereof as drugs
AU772782B2 (en) Cyclic peptide derivatives as inhibitors of integrin alphavbeta6
KR101368607B1 (ko) 메타스틴 유도체 및 그의 용도
KR100306506B1 (ko) 폴리펩티드봄베신길항제
RU2249599C2 (ru) Циклопептиды, способ их получения и применение в качестве ингибиторов или активаторов антиогенеза
CN101426808A (zh) 新颖的蛋白质转导结构域及其应用
US6335320B1 (en) Method of treating fibrotic conditions
RU2380371C2 (ru) Низкомолекулярные производные пептидов как ингибиторы взаимодействия ламинина/нидогена
US6716963B1 (en) Peptide antiangiogenic drugs
US6664369B1 (en) GnRH analogues with antitumour effects and pharmaceutical compositions thereof
CZ20014484A3 (cs) Inhibitory integrinu alfa v beta 6
KR20210018450A (ko) 비후성 반흔의 형성 억제용 조성물
EP0728012B1 (en) NOVEL GnRH ANALOGUES WITH ANTITUMOUR EFFECTS AND PHARMACEUTICAL COMPOSITIONS THEREOF
US20250388623A1 (en) Peptide inhibitor and use thereof
WO1998020887A1 (en) Polyphosphoinositide binding peptides for intracellular drug delivery
Siemion et al. Analogs of RGDVY and GRGD peptides inhibit Mycobacterium kansasii phagocytosis
JP2002500195A (ja) 自己免疫疾患を治療するためのフィラグリン由来シトルリンペプチドの使用
KR20010101178A (ko) αｖβ６ 인테그린 저해제

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: UCB

Free format text: FORMER NAME: UCB S.A.

FGA Letters patent sealed or granted (standard patent)